PEAPACK GLADSTONE FINANCIAL CORP
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1050743
BEDMINSTER, NJ
Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$857,056
+$149,358 QoQ
Shares Held
10,950
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#324
of 664 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $4,960,618 across 6 Biotechnology names. HALO ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,837 | $1,768,982 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
5,875 | $897,817 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
This page
|
10,950 | $857,056 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,654 | $821,591 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
6,988 | $381,125 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
13,451 | $234,047 |
All Filings in HALO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $857,056 | 10,950 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $707,698 | 10,950 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $757,125 | 11,250 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $847,077 | 11,550 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $600,831 | 11,550 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $737,005 | 11,550 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $360,965 | 7,550 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $661,122 | 11,550 | Shares | Defined | 2024-11-26 | |
| 2024-06-30 | $604,758 | 11,550 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $319,338 | 7,850 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $302,998 | 8,198 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $312,590 | 8,183 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $295,160 | 8,183 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $312,508 | 8,183 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $701,747 | 12,333 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $329,486 | 8,333 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $366,652 | 8,333 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $332,320 | 8,333 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $335,069 | 8,333 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $338,986 | 8,333 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $378,129 | 8,327 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $347,152 | 8,327 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $355,176 | 8,316 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $236,520 | 9,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $241,290 | 9,000 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||